Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Polydopamine-Decorated Orlistat-Loaded Hollow Capsules with an Enhanced Cytotoxicity against Cancer Cell Lines
Xiaqing Zhou et al.
MOLECULAR PHARMACEUTICS (2019)
Stereochemical Strategy Advances Microbially Antiadhesive Cotton Textile in Safeguarding Skin Flora
Jiangqi Xu et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT-tamoxifen hybrid therapy
Theodossis A. Theodossiou et al.
NPJ BREAST CANCER (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Fatty acid synthase as a potential therapeutic target in feline oral squamous cell carcinoma
J. Z. Walz et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy
Alejandro Schcolnik-Cabrera et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
M. Danaei et al.
PHARMACEUTICS (2018)
Dynamic agent of an injectable and self-healing drug-loaded hydrogel for embolization therapy
Xiaqing Zhou et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2018)
Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
Quantifying ROS levels using CM-H2DCFDA and HyPer
Monika Oparka et al.
METHODS (2016)
The utility of HepG2 cells to identify direct mitochondrial dysfunction in the absence of cell death
Laleh Kamalian et al.
TOXICOLOGY IN VITRO (2015)
Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells
Ying Qu et al.
PLOS ONE (2015)
Blocking Lipid Synthesis Overcomes Tumor Regrowth and Metastasis after Antiangiogenic Therapy Withdrawal
Nor Eddine Sounni et al.
CELL METABOLISM (2014)
Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields
Yanlan Liu et al.
CHEMICAL REVIEWS (2014)
Protective and toxic roles of dopamine in Parkinson's disease
Juan Segura-Aguilar et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Characterization of Carbonized Polydopamine Nanoparticles Suggests Ordered Supramolecular Structure of Polydopamine
Xiang Yu et al.
LANGMUIR (2014)
MITOCHONDRIAL REACTIVE OXYGEN SPECIES (ROS) AND ROS-INDUCED ROS RELEASE
Dmitry B. Zorov et al.
PHYSIOLOGICAL REVIEWS (2014)
Core-Shell Fe3O4 Polydopamine Nanoparticles Serve Multipurpose as Drug Carrier, Catalyst Support and Carbon Adsorbent
Rui Liu et al.
ACS APPLIED MATERIALS & INTERFACES (2013)
Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics
BreeAnn N. Brandhagen et al.
BMC CANCER (2013)
pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells
R. Vivek et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
The pH-controlled nanoparticles size of polydopamine for anti-cancer drug delivery
Chia-Che Ho et al.
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE (2013)
Tunable Cytotoxicity of Rhodamine 6G via Anion Variations
Paul K. S. Magut et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Determination of Drug Release Kinetics from Nanoparticles: Overcoming Pitfalls of the Dynamic Dialysis Method
Sweta Modi et al.
MOLECULAR PHARMACEUTICS (2013)
Fatty Acid Synthase Is a Key Target in Multiple Essential Tumor Functions of Prostate Cancer: Uptake of Radiolabeled Acetate as a Predictor of the Targeted Therapy Outcome
Yukie Yoshii et al.
PLOS ONE (2013)
Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: Role of cell survival regulatory molecules
Shiva Kant et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas
F. Seguin et al.
BRITISH JOURNAL OF CANCER (2012)
Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal
Hui-Yen Chuang et al.
BIOMEDICINE & PHARMACOTHERAPY (2011)
PKD2 mediates multi-drug resistance in breast cancer cells through modulation of P-glycoprotein expression
Jiao Chen et al.
CANCER LETTERS (2011)
Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(L-histidine-)-poly(L-lactide) nanoparticles
Rong Liu et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis
Karina G. Zecchin et al.
LABORATORY INVESTIGATION (2011)
Development of Resistance towards Artesunate in MDA-MB-231 Human Breast Cancer Cells
Beatrice Bachmeier et al.
PLOS ONE (2011)
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
T. Mashima et al.
BRITISH JOURNAL OF CANCER (2009)
Self-Polymerization of Dopamine as a Versatile and Robust Technique to Prepare Polymer Capsules
Almar Postma et al.
CHEMISTRY OF MATERIALS (2009)
Inhibition of Fatty Acid Synthase by Orlistat Accelerates Gastric Tumor Cell Apoptosis in Culture and Increases Survival Rates in Gastric Tumor Bearing Mice In Vivo
Shawn Dowling et al.
LIPIDS (2009)
Monoamine oxidase inactivation: From pathophysiology to therapeutics
Marco Bortolato et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model
Marco A. Carvalho et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Progress in nanoparticles characterization: Sizing and zeta potential measurement
Renliang Xu
PARTICUOLOGY (2008)
Mussel-inspired surface chemistry for multifunctional coatings
Haeshin Lee et al.
SCIENCE (2007)
Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells
Joy L. Little et al.
CANCER RESEARCH (2007)
SMART drug delivery systems: Double-targeted pH-responsive pharmaceutical nanocarriers
R. M. Sawant et al.
BIOCONJUGATE CHEMISTRY (2006)
Mitochondrial ROS-induced ROS release: An update and review
Dmitry B. Zorov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2006)
Differential control of growth, cell cycle progression, and expression of NF-κB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens
TC Hsieh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Antitumoral actions of the anti-obesity drug orlistat (Xenical™) in breast cancer cells:: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene
JA Menendez et al.
ANNALS OF ONCOLOGY (2005)
Orlistat, a new lipase inhibitor for the management of obesity
AM Heck et al.
PHARMACOTHERAPY (2000)
Share Paper
